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Summary 
Lipoxin A4 (LXA4) triggers selective responses with human neutrophils that are pertussis toxin 
sensitive and binds to high affinity receptors (Kd =  0.5  +  0.3 nM) that are modulated by stable 
analogues of guanosine 5'-triphosphate (GTP). Here, we characterized  [11,12-3H]LXA4 specific 
binding with neutrophil granule and plasma membranes, which each display high affinity binding 
sites (Kd  =  0.7  _+  0.1 riM) that were regulated by GTP3,S. Since functional LXAa receptors 
are inducible in HL-60 cells, we tested orphan cDNAs encoding 7-transmembrane region receptors 
cloned from these cells for their ability to bind and signal with LXA4. Chinese hamster ovary 
(CHO) cells transfected with the orphan receptor eDNA (plNF114) displayed specific 3H-LXA4 
high affinity binding (1.7 nM). When displacement of LXA4 binding with plNFl14-transfected 
CHO cells was tested with other eicosanoids, including LXB4, leukotriene D4 (LTD4), LTB4, 
or prostaglandin E2, only LTD4 competed with LXA4, giving a Ki of 80 nM. In transfected 
CHO  cells, LXA4  also  stimulated  GTPase  activity  and  provoked the  release  of esterified 
arachidonate,  which proved to be pertussis toxin sensitive. These results indicate that plNF114 
eDNA encodes a 7-transmembrane region-containing protein that displays high affinity for 3H- 
LXA4 and transmits LXA4-induced signals. Together, they suggest that the encoded protein is 
a candidate for a LXA4 receptor in myeloid cells. 
poxygenase (LO)l-derived eicosanoids are important lipid 
mediators (1). The 5-LO-derived products include leu- 
kotriene B4 (LTB4), a potent stimulus for phagocytic cells, 
and peptido-leukotrienes C4, D4, and E4, which are potent 
bronchoconstrictors and are associated with the pathogen- 
esis of asthma (1). Lipoxins (LX) are a newer class of bioac- 
tive LO-derived products that are generated by the interac- 
tions of either 5- and 12-LO and/or 15- and 5-LO followed 
by subsequent reactions (for a review see reference 2). The 
LXs are functionally distinct from leukotrienes and other ei- 
cosanoids and are primarily generated in human tissues during 
cell-cell interactions that are exemplified by leukocyte-platelet 
interactions  (2).  LXA4  displays  intriguing biological re- 
1  Abbreuiations used in this  paper: AMP-PNP, 5'-adenylylimidodiphosphate; 
CHO, Chinese  hamster ovary cells; DPBS/PBS,  Dulbecco's  PBS; PBS  2- 
without  divalent  cations;  FPR, formyl  peptide  receptor;  GTPyS,  guanosine 
5'-O-(3-thiotriphosphate);  leukotriene  B4 (LTB4), 5S,12R-dihydroxy-6,14- 
cis-8,10-trans-dihydroxyeicosatetraenoic acid; leukotriene  D4 (LTD4), 5S- 
hydroxy-6R-(S-cystdnyl-glycynyl)-7,9-trans-ll,14-cis-eicosatetraenoic acid; 
lipoxin A4 (LXA4), 5S,6R,15S-trihydroxy-7,9,13-trans-ll-cis-eicosatetra- 
enoic acid; lipoxin  B4 (LXB4), 5S,14R,15S-trihydroxy-6,10,12-trans-8-cis- 
eicosatetraenoic  acid; LO, lipoxygenase;  PGE2, 9-oxy-11o~,15S-dihydroxy- 
5-cis-13-trans-prostadienoic acid; PT, Pertussis toxin holotoxin. 
sponses in several tissues (2), and with neutrophils they in- 
volve G protein-mediated signal transduction events (3-5). 
A LXA4 receptor is induced in HL-60 cells upon differenti- 
ation, and it activates phospholipase D  (5). LXA4-induced 
lipid remodeling events are similar to those of other leuko- 
cyte stimuli (i.e., LTB4 and FMLP), but specifically differ by 
triggering only selective responses (in the nanomolar range) 
without initiating aggregation or degranulation (3). In ad- 
dition, LXA4 modulates and inhibits neutrophil responses 
elicited by receptor-mediated stimuli including FMLP (6-8) 
and LTB4 in vivo (9). Thus, LXA4 has a selective profile of 
action of interest in multicellular responses. 
Albeit  some structural  similarities  between LXA4 and 
LTB4 exist (e.g., are identical between C1-C5), LXA4 recep- 
tor interactions in neutrophils involve binding sites that are 
not recognized by LTB4 (3, 4). Peptido-leukotrienes, the ac- 
tions of which are antagonized by LXA4 in vivo and in vitro 
(10-12), compete with 3H-LXA4 binding in neutrophils (4). 
Interactions between LXA4 and LTD4 were also noted with 
human endothelial cells, where a  putative LTD4 receptor 
binds 3H-LXA4 with an affinity m20-fold lower than that 
observed with neutrophils (5). With the exception of en- 
dothelial and mesangial cells, where LXA4 is blocked by a 
LTD4  receptor  antagonist  (SKF104353),  LXA4  specific 
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cluding red cells, platelets, or lymphocytic ceU lines (5, 10). 
Thus, in addition to binding with specific leukocyte LXA4 
receptors, it appears that LXA4 can also interact with LTD4 
receptor sites which, in certain tissues, may represent a subset 
or subtype  of LTD4 receptors (i.e., LTD4/LXA4-r). 
These results,  and  the finding  that functional LXA4 re- 
ceptors are inducible in promyelocytic lineages (HL-60 ceils) 
(5), as is the case for other receptors (13-15), prompted us 
to  investigate  whether  orphan  7-transmembrane  receptor 
cDNAs recently isolated from myeloid lineages (16, 17) could 
encode for LXA4 receptors or binding  proteins. 
Materials and Methods 
Materials.  Tritiated LXA4 ([11,12-3H]LXA4) (40 Ci/mmol) was 
obtained from a custom catalytic hydrogenation of 11,12-acetylenic 
LXA4 methyl ester performed by New England Nuclear (NEN), 
DuPont Co. (Boston, MA) and purified as in references 4 and 5. 
[-y-32p]GTP (30 Ci/mmol),  3H-FMLP (53.6 Ci/mmol), and 3H- 
arachidonate (100 Ci/mmol) were also from NEN, DuPont Co. 
N-(-p-amylcinnamoyl)anthranilic  acid and synthetic LXA4, LXB4, 
LTD4,  prostaglandin  E2 (PGE2),  and LTB4 were obtained from 
Cascade  Biochem Ltd.  (Reading,  Berkshire, England). Pertussis 
toxin (holotoxin) (PT) was purchased from List Biological Labora- 
tories, Inc. (Campbell, CA). Dulbecco's PBS (DPBS) and cell cul- 
ture reagents were from Whittaker M. A. Bioproducts (Walkers- 
ville, MD), and plasticware was from Marsh Biomedical Products, 
Inc. (Rochester, NY). GTP'yS, FMLP, and 4-p-bromophenacyl bro- 
mide were from Sigma Chemical Co. (St. louis, MO), and silicon 
oil was  from Htils America (Bristol, PA). 
Neutrophil Isolation and Subcellular Fractionation.  Human neu- 
trophils were obtained by the modified B6yum method (18) from 
fresh heparinized blood after venipuncture of healthy normal volun- 
teers. Cell suspensions in PBS were monitored for cell number and 
viability.  To obtain plasma membrane- and granule-enriched frac- 
tions, neutrophil fractionation was carried out as in reference 4. 
Briefly, after suspension  in HBSS  2- containing 0.1% albumin and 
diisopropyl fluorophosphate (5 mM) for 30 mAn at 37~  neutro- 
phils were adjusted to 4  x  107 cells/ml of HBSS  2-  with added 
MgClz (2.5 mM). Next, cells kept at 4~  throughout the proce- 
dure were sonicated four times using an ice-cold probe (100 W, 
15 s). Crude sonicates  were supplemented with EDTA (2.5 mM 
final) and sequentially centrifuged at 150 (10 man), 18,000 (30 mAn), 
and 100,000 g (1 h). Granule- and plasma membrane-enriched frac- 
tions were recovered in the 18,000 and 100,000 g pellets,  respec- 
tively, as indicated by the monitoring of marker enzymes (cf. 4). 
Expression of Orphan Receptors in Chinese Hamster Ovary Cells. 
Cells were grown in 100-ram pet  i  dishes incubated in a 5% CO2 
atmosphere at 37~  in aMEM supplemented with adenosine, deox- 
yadenosine, and thymidine in addition to serum and antibiotics. 
Chinese hamster ovary (CHO) cells were transfected using the 
DEAE-dextran procedure (19) for transient expression of plasmid 
DNAs for orphan receptors (i.e., denoted pINF114, plNF154) and 
formyl peptide receptor (FPR) (16, 17). The sequences of cDNA 
for pINF114 (17) and pINF154 (16) and deduced amino acid se- 
quences  have  been  reported.  48  h  after  transfection  (10  #g 
DNA/dish),  cells were detached using PBS  2-  containing EDTA 
(5 raM) (3 rain, 20~  and centrifuged (200g, 10 rain) after addi- 
tion of  complete oeMEM (2:1 vol/vol). CHO cellpermeabilization 
was achieved with two cycles of freezing (dry ice-acetone bath) fol- 
lowed by thawing at room temperature. All cell preparations were 
resuspended in PBS  2+ before being used in binding assays. 
Ligand Binding Assays.  [3H]LXA4 binding was performed as 
in (4,  5).  Briefly, centrifugation at high speed (30 s,  12,000 g) 
through silicon oil was used with intact cell suspensions  (2-5  x 
106 cell/0,5-ml aliquots),  and filtration through microspin filter 
units (0.45 #m cellulose  acetate;  PGC Scientifics, Gaithersburg, 
MD) was used with both subcellular  fractions and permeabilized 
cell suspensions.  Incubations were performed at 4~  for the indi- 
cated duration in the presence or absence of  excess unlabeled homo- 
or hetero- ligands  (1-3 log excess) to determine total and specific 
binding. Both pellets and filters were next resuspended in scintilla- 
tion cocktail and radioactivity determined by a Wallac 1409 3-counter 
(Pharmacia-Wallac Oy, Turku, Finland). Results obtained were ana- 
lyzed with the Ligand program (Biosoft Elsevier). 
GTPase Assays.  GTPase activity was determined in transfected 
CHO cells by a modification of the method described  by Cassel 
and Selinger (20). CHO cells were harvested 72 h after transfec- 
tion with pINF114 or a mock vector. Adherent cells were detached 
from  culture  plates  using  PBS  2-  (5  mM  EDTA).  Cells  were 
washed with PBS and resuspended  (107 cells/ml) in ice-cold buffer 
(containing 138 mM KC1, 25 mM Tris-HC1, I mM EGTA, 1 mM 
MgC12, 0.4 mg/ml creatine kinase,  5 mM phosphocreatine, 0.8 
mM 5'-adenylylimAdodiphosphate  [AMP-PNP], 0.1 mM ATP, 0.1 
#M  GTP,  and  0.5  /~M  [3~-32P]GTP). Cells  in  suspension  were 
transferred to electroporation cuvettes kept in ice and were per- 
meabilized with one discharge of 875 V/cm from a 250 #F capac- 
itor (cat. no. 165-2098; Bio-Radiations, Bio-Rad Laboratories, Rich- 
mond, CA). Uptake of 32p by cells was monitored and averaged 
~12% of total ['y-32P]GTP in solution. Samples were transferred 
to a 30~  water bath and incubated for the indicated times in the 
presence of agonists.  Aliquots (100 #1) were removed at indicated 
times and added to 750 #1 of ice-cold NaH2PO4 (10 mM, pH 2.0), 
containing 5% (wt/vol) charcoal and 0.1% Triton X-100, and vor- 
texed.  After incubating on ice for at least  15 man, samples were 
centrifuged for 3 rain at 3,000 g, and radioactivity in 400 #1 of 
supernatant was determined by liquid scintillation counting. The 
rate of agonist-dependent GTPase activity was determined by sub- 
tracting the amount of free 32pi at time zero from values at desig- 
nated intervals and calculating individual slopes. The rates of GTP 
hydrolysis in pINF114 CHO cells were equivalent to mock trans- 
fected cells with  vehicle  and  PGE2,  whereas,  with  LXA4,  the 
rates in plNF114 cells were more than three times higher. Vehicle 
added to mock transfected CHO cells typically gave values of 0.06 
pmol/min/106 cells. 
Release of Estetified 3H-Arachidonate  from CHO Cells.  48 h after 
transfection, CHO cells were incubated for 3 h at 37~  in com- 
plete oeMEM (5 ml/dish) containing 0.1/~Ci of 3H-arachidonate/ 
ml. Esterification of 3H-arachidonate  represented 71.0  +  12.5% 
of added material. Phospholipid class distribution was resolved by 
two-dimensional TIC (3) (with *81.1% of esterified 3H-arachi- 
donate in the total phospholipid fractions), and the individual classes 
were phosphatidylserine/phosphatidylinositol,  27%; phosphatidyl- 
choline, 24.2%; and phosphatidylethanolamine, 29.9% of the es- 
terified label.  Next, cells were washed twice and resuspended in 
PBS  2-  (5  mM EDTA).  After resuspension  in  PBS  2+  (2  x  106 
cells/ml), cells transfected with either FPR- or plNFll4-carrying 
vectors were incubated  at  37~  with  selected  putative ligand. 
LXA4-induced (10 -9 M)  3H-arachidonate  release from plNF114 
transfected CHO ceils was 2.4-11.3% of incorporated 3H-arachi- 
donate. This was equivalent to 24.4-39.7% of the maximal release 
obtained  using  the  calcium  ionophore A231s7 (2.5  /zM).  Back- 
ground values obtained with mock and plNF114 transfected CHO 
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3H-arachidonate. In parallel determinations,  cells were exposed to 
two commonly used phospholipase A2 inhibitors, 4-F-bromophe- 
nacyl bromide or N-(-p-amylcinnamoyl)anthranilic acid, 10 min be- 
fore agonist additions. At indicated time intervals, aliquots (1 ml) 
were layered on a cushion of silicon and centrifuged (30 s, 12,000 g). 
The radiolabel content of individual superuatants (750-/~1 aliquots) 
was determined  (21). 
Northern Blot Analysis.  Multiple human tissue Northern blots 
(Clontech,  Palo Alto,  CA)  containing  ~2.0  /~g/lane poly(A +) 
RNA were probed using a plNF114 open reading frame that had 
been labeled with [c~-3~P]dCTP by random priming,  as described 
(13). Hybridization  was done at 42~  for 18 h. After washing (as 
described in legend to Fig. 6), the blot was exposed to X-Omat 
AK5 film at  -70~  overnight with an intensifying screen, after 
which they were stripped and reprobed with a 32p-labeled human 
actin (Clontech)  probe using identical conditions. 
Constructs.  FLAG-FPR and FLAG-pINF114 were constructed 
employing  an  octapeptide  (DYKDDDDK)  encoding  sequence 
termed FLAG as in (22). All constructs were inserted into the EcoRI 
site of pRc/CMV that had been mutated so as to have a single 
EcoRI site located within the cloning  site (22). 
Results 
Specific binding of [11,12-3H]LXA4 in human neutrophils 
gives a Ka of 0.5  +  0.3  nM and is distributed  in plasma 
membrane- (~42%), granule-  (34.5%), and nuclear-  (23.3%) 
enriched fractions.  3H-LXA4 binding with intact neutrophils 
and plasma membrane is modulated by GTP stable analogs 
(4).  To determine whether the interaction of 3H-LXA4 with 
different  subcellular  fractions  gives  similar  characteristics, 
[11,12-3H]LXA4  specific  binding  with  granule  membrane 
was  compared  with  that  observed  with  plasma  mem- 
brane-enriched fractions. Isothermic binding was performed 
at 4~  with ~H-LXA4 (0.1-15 nM) in the presence or ab- 
sence of a 3  log excess  of unlabeled  LXA4.  Results  from 
Scatchard  analyses  show  that  3H-LXA4 binds  neutrophil 
granule membrane-enriched  fractions with comparable Ka 
(0.8 nM) but larger B~, (4.1  x  10 -11 M) than with plasma 
membranes  (Ka 0.7 riM,  Bm~, 2.1  x  10-11 M) (Fig.  1). In 
addition, exposure of granule membrane fractions to GTPqrS, 
a stable analog of GTP, reduced the Bmax (2.7  x  10 -11 M) 
to  values  similar  to  those  observed for  3H-LXA4  specific 
binding with plasma membranes (Fig. 1). These findings sug- 
gest  that  3H-LXA4  binding  to  intact  neutrophils  and 
granule membrane-associated fractions involves one class of 
binding  sites.  Therefore,  a higher  abundance  of LXA4 re- 
ceptors is likely for total cellular copies than that calculated 
solely on the basis of cell surface receptor expression  (~1,800/ 
cell in neutrophils, cf. 4). This granule membrane-associated 
fraction of LXA4 binding sites may represent a reserve store 
as documented for other  neutrophil  receptors (23). 
Since LXA4 specific  and functional receptors present in 
neutrophils  are induced upon differentiation in HL-60 cells 
(5), we assessed orphan cDNAs recently cloned from libraries 
derived from differentiated myeloid lineages.  Several orphan 
receptor cDNAs have been isolated that are members of the 
7-transmembrane domain G protein-coupled receptor family 
and also display general  sequence homology to the FMLP 
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Figure  1.  Scatchard  plots of 3H-LXA4  binding with isolated neutro- 
phil granule and plasma membranes: modulation by GTPyS. Neutrophil 
subcellular fractions were obtained as in the Materials and Methods. In- 
creasing concentrations of 3H-LXA4 (0.3-15 nM) with or without a 3 
log order of magnitude excess of unlabeled LXA4 were added to isolated 
granule membranes or plasma membranes (50/xg protein/determination), 
and specific  binding was determined (4~  10 min). Parallel experiments 
with granule membranes were performed after incubation with GTPyS 
(20 #M, 3 min). Results  represent the average  values of duplicate determi- 
nations obtained with neutrophils from two separate donors. 
receptor (16, 17). High affinity ligands have not been identified 
for these sequence-related putative receptors, and they were 
coined FMLP homologous orphan receptors (16) or related 
FMLP receptors (RFP; 17). CHO cells were transfected with 
these  cDNAs  and  tested  for  their  ability  to  bind  [11,12- 
3H]LXA4 (48 h after transfection).  As shown in Fig. 2 (le~), 
CHO cells transfected with plNF114 display specific binding 
with LXA4 (Ka ~5 nM), and, for purposes of direct com- 
parison,  those transfected with FPR (right)  displayed high 
affinity binding for its ligand FMLP (Kd ~5 nM). Nonspe- 
cific binding was comparable with both ligands (Fig. 2). 3H- 
LXA4  did  not  display  high  affinity binding  with  several 
other related orphan 7 transmembrane region receptors trans- 
fected in CHO cells including plNF154  (see 16,  17)  (data 
not shown).  Albeit a low abundance of ~2,000 LXA4 re- 
ceptors per cell was observed with intact cells (Fig.  2), the 
receptor abundance may reflect, in part, transfection efficiency 
that is usually 20-30% with DEAE-dextran transfection.  Also, 
posttranscriptional  modification and/or intracellular  trafficking 
could lead to partitioning  among cellular membranes other 
than the surface plasma membrane,  which may give lower 
receptor B~  with transfected cells. To test this hypothesis, 
we examined permeabilized cells after transfection for specific 
binding  with  both  ligands.  Experiments  with  3H-FMLP 
(n  =  4) and 3H-LXA4 (n  =  7) indicate that Ka values were 
unaltered after permeabilization of transfected cells (intact 5.6 
nM versus permeabilized 5.0 nM for FMLP; and intact 6.5 
nM versus permeabilized 7.3 nM for LXA4). In contrast, the 
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Figure  2.  Ligand binding with trans- 
fected CHO cells. After transfection (48 h) 
with either FPR or plNF114,  CHO cells 
were  harvested  (PBS  2-  EDTA  5  mM), 
washed twice with PBS  2§ (1,100 rpm, 10 
min) and adjusted to 107 cells/ml. Aliquots 
(0.5 ml containing 5  x  106 cells) were in- 
cubated  with  either  3H-FMLP  (5  riM, 
FPR transfected CHO, right) or 3H-LXA4 
(0.5 riM, plNF114 transfected CHO, left), 
in the absence  or presence of increasing 
quantities of unlabeled homoligands (1-3 
log order molar excess). Parallel determi- 
nations were obtained for intact (top) or per- 
meabilized (bottom) cell suspensions. Results 
are the average of duplicate determinations 
and are representative  of more than three 
separate experiments with each transfectant. 
(Insets)  3H-ligand  binding  displacement 
curves reported as percent remaining after 
addition of unlabeled ligand (mean of n = 
3 separate experiments for each ligand). 
Bmax values  obtained with permeabilized cells were about 
five- to sevenfold higher than those with intact cells (2.3  x 
10 -1~  x  10 -11M  for FMLP and 3.6  x  10 -1~ 
versus 5.2  x  10-11 M  for LXA4) (see Fig. 2, bottom).  Next, 
pINF114 cDNA was modified at the corresponding NH2- 
terminus sequence to contain a FLAG peptide-encoding se- 
quence (22). After transfection, FLAG-plNF114-expressing 
cells were harvested (48 h) and fractionated, and individual 
enriched fractions for nuclei, organdie, and plasma membrane 
were electrophoresed by polyacrylamide gel.  Western blot 
analysis with a mouse mAb recognizing the FLAG peptide 
portion showed the distribution of plNF114 construct as- 
sociated with plasma membranes as "~35%, organelle pellet 
"~52%,  and nuclei '~13%. 
Given the higher Bm~ obtained with permeabilized cell 
suspensions and the finding that >50% ofplNFll4-encoded 
protein was associated with intracellular fractions,  permea- 
bilized  transfected  CHO cells were used to further charac- 
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Figure 3.  Scatchard plot of 3H-LXA4 binding to plNFl14-transfected 
CHO cells, plNF114-transfected CHO cells (107 cells/0.5 ml) were per- 
meabilized and incubated (4~  10 min) with an increasing concentration 
of SH-LXA4 (0.3-15 nM) with or without 3 log order excess of unla- 
beled LXA4 (n  =  8).  Results are from computer-assisted analysis of 
isothermic binding data analyzed using the Ligand program. 
Table  1.  Eicosanoid  Competition  of 3H-LXA4  Binding 
with plNF114-transfected  CHO  Cells 
Compound  Ki 
nM 
LXA~  5.6 
LXB4  NS" 
LTD4  79.9 
LTB4  NS* 
PGE2  NS* 
After transfection with plNF114 (48 h), intact CHO cells were harvested 
in PBS  2- (5 mM EDTA), washed twice in PBS  2+ and adjusted to 4-10 
x  107 cells/ml. Aliquots (200 #1) were added to microcentrifuge tubes 
containing 800 #1 of PBS  2+  and 3H-LXA4 (0.3  nM final) alone, or in 
the presence of increasing concentrations of indicated compounds (3-300 
nM). All solutions were kept at 4~  Cells were incubated for 5 rain 
followed by layering aliquots (0.5 ml) from each experimental point on top 
of a silicon oil cushion (density =  1.013). Samples were centrifuged and 
pellet radioactivity measured by scintillation counting. Ki values reported 
are obtained from evaluating displacement curves via the Ligand program. 
Results are the means  of three separate  experiments. 
* Ligand program analysis of data failed linear regression for competi- 
tion in the concentration range tested (3-300 nM). 
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Figure 4.  Structure-function relationship of ligand-induced GTPase ac- 
tivity in plNFl14-transfected CHO cells. Rates of [3,-32p]GTP hydrolysis 
were determined by calculating the linear regression of 32p release in the 
initial 30  s  after  ligand addition  (10 -7  M)  to  electropermeabilized, 
plNF114-transfected CHO cells (+ SEM, n = 3). (*) Significantly higher 
than vehicle and other ligands by Student's t test (p < 0.05). (Inset) GTPase 
activity of transfected CHO cells minus activity obtained with mock trans- 
letted CHO cells, expressed as percent LXA4-indueed GTPase activity; 
results are from one experiment (d =  2) representative of three separate 
experiments. 
terize  3H-LXA4  binding to  the  plNF114  product.  Time 
course of label association at 4~  gave results similar to those 
obtained with neutrophils, and equilibrium binding was ob- 
tained within 5 min (data not shown). Analysis ofisothermic 
binding of 3H-LXA4 (1-15 nM, 5 min at 4~  to plNF114 
transfected CHO cells gave a Ka of 1.7 +_ 0.8 nM and a Bmax 
of 3.8  -+ 0.5  x  10 -1~ M (Fig. 3). These values are in agree- 
ment with the Ka values obtained for both neutrophil and 
retinoic acid differentiated HL-60 cells (5). 
LXA4 binding with neutrophils and HL-60 cells is stereo- 
selective in that neither LTB4 nor LXB4 competes for LXA4 
binding (4). Structural requirements for 3H-LXA4 binding 
with plNF114-transfected CHO cells were examined with 
LXB4, LTD4, LTB4, or PGE2. Only LTD4 proved effective 
in displacing tritiated LXA4 binding with plNF114 trans- 
fected CHO cells (Ki ~80 nM, Table 1). Results are consis- 
tent with  those obtained with neutrophils (4,  5) where, 
among the compounds examined, only LTD4 competed with 
3H-LXA4 binding (Ki ~70 riM).  These findings indicated 
that specific LXA4 binding with plNF114-transfected  CHO 
cells is selective, prompting the assessment oftransmembrane 
signaling. 
Does plNF114 Transduce  LXA4 Signals?  As shown in Fig. 
4,  after  transfection of CHO  cells with plNF114, LXA4 
specifically induced GTPase  activity.  The maximum rate 
triggered by LXA4 was reached within 30 s and proved to 
be concentration dependent (data  not shown). LXB4 and 
PGE2 gave significantly lower levels of GTPase activity than 
LXA4.  LTD4  also stimulated GTPase  activity in plNF114 
transfectants  when activity associated with mock transfec- 
tants assayed in parallel was subtracted (Fig. 4, inset). These 
results suggest that the structure--function relationship for 
Figure 5.  Time course of LXA4-induced release of 3H-arachidonate 
from transfected CHO cells. After labeling with 3H-C20:4 (37~  3 h), 
transfected CHO cells were kept at 37~  and exposed to either LXA4 
(10 -9 M: mock transfected [I]; plNF114 transfect [[-]]) or FMLP (5  x 
10 -7 M, FPR transfect [0]). At the indicated intervals, aliquots (2  x 
106 cells) were layered onto a cushion of silicon oil and centrifuged. The 
3H-arachidonic  acid content released into the supernatants was determined. 
Parallel determinations were performed with ligands and vehicle in trans- 
fected and mock transfected CHO cells. Values  obtained with vehide alone 
(EtOH, 0.1% final) in mock and transfected CHO cells were subtracted 
from those obtained with respective ligands. Results are representative of 
three separate  experiments with duplicate determinations. (Inset) The profile 
as percentage of maximal release. Results are the mean +_ SEM of three 
separate experiments. 
stimulating GTPase activity is similar to that obtained for 
3H-LXA4 binding competition (Table 1). 
LXA4 stimulates arachidonate release (2,  3),  and CHO 
cells can mobilize arachidonate in response to ligand-specific 
stimulation of transfected receptors (21). Next, plNFl14-CHO 
and mock transfected CHO cells were labeled with 3H-ara- 
chidonate and  exposed to  LXA4  (10 -9  M)  to  determine 
whether  this  receptor  can  stimulate  release.  A  specific, 
LXA4-dependent release  of esterified  3H-arachidonic  acid 
was obtained with pINF114 transfected CHO cells (Fig. 5). 
Time course experiments showed maximal release in the 3-5 
min interval with a subsequent decline. A similar profile was 
also observed for FMLP-induced release of esterified 3H-ara- 
chidonic acid with FPR transfected CHO cells, reported for 
purposes of direct comparison (Fig.  5 and its inset). Both 
LXA4- (10-9 M) and FMLP (10-7 M)-induced arachidonate 
release proved sensitive to phospholipase inhibitors N-(-p-amyl- 
cinnamoyl)anthranilic acid (100 #M) (n =  3) and 4-p-bromo- 
phenacyl bromide (n  =  1; 50/~M) (data not shown). Selec- 
tive inhibition of LXA4-induced release of 3H-arachidonate 
from plNF114 transfected CHO cells was observed when la- 
beled cells were exposed to PT (4-6 h, 37~  before agonist 
addition (Table 2). To ensure that PT treatment did not simply 
impact in the agonist's temporal response,  time course of 
3H-arachidonate release was monitored at 0-, 5-, and 10-min 
intervals (data not shown). Thus, CHO cells transfected with 
plNF114 specifically bind and give responses with LXA4. 
Preliminary studies on the distribution of mRNA for this 
receptor showed that the most abundant levels for the spe- 
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Percentage of 3H-Arachidonate release 
Mock CHO cells  plNFll4 CHO cells 
Az31s  7  LXA4  A23187  LXA4 -  (percent inhibition) 
PT  (2.5 /zM)  (10 -9 M)  (2.5 /~M)  (10 -9 M) 
(rig~rot) 
0  100.0"  0.0  100.0"  36.5  -  (0.0%) 
10  100.0  0.0  100.0  3.7  -  (89.9%) 
100  100.0  0.0  100.0  0.0  -  (100.0%) 
After 3H-arachidonate  labeling (37~  3 h), cells were exposed to increasing concentrations  (0-10-100 ng/ml) of PT (37~  6 h). At 5 rain after 
additions, 3H-arachidonate  release was measured as described in the legend to Fig. 5. Results are the average of duplicate determinations  from a 
representative of four separate experiments. 
* Data are reported as percentages obtained  with each addition  relative  to A23187 (2.5 #M) stimulation  after subtraction of values obtained  with ve- 
hicle alone. 
des of interest (i.e., •1.8-2.0  kb) were associated with human 
lung, followed by placenta (Fig.  6),  tissues known to have 
a relatively high degree of phagocytic cell infiltrates.  Other 
bands were observed  that crosshybridize with this receptor 
(Fig. 6). The 1.0-kb band is unknown. The 1.4-kb band cor- 
responds to the FMLP receptor size (24).  The 2.4-2.6-kb 
band is also  FMLP-like, but distinct from LXA4 receptor. 
Bands of higher molecular size may represent presplicing forms 
of these receptors.  Both the FMLP and the LXA4 receptor 
genes possess a 5.0-kb intron (24) that is spliced to generate 
the open reading frame. 
Figure  6.  Tissue distribution of LXA4 receptor mRNA. Multiple 
human tissue blot was  probed with 32p-pINF114 and 32p-actin. (A) 
plNF114 probe. (B) Actin probe. After hybridization,  blot was washed 
at room  temperature  (2 x SSC, 0.1% SDS) for 40 rain  followed  by a second 
(40 min) wash in 0.1x SSC, 0.1% SDS at 50~ 
Discussion 
The present results establish that the interactions of LXA4 
with cells expressing plNFll4, a previously isolated orphan 
receptor of the 7-transmembrane region class (16, 17), meet 
the criteria commensurate with ligand-receptor interactions 
and transmembrane signaling (25). Namely, transfected cells 
display specific binding with 3H-LXA4 that is displaced with 
excess unlabeled ligand (Fig.  2).  Binding was selective for 
LXA4 in that other eicosanoids including LXB4, LTB4, and 
PGE2 did  not  displace  LXA4  specific  binding  (Table 1). 
CHO cells possess the components required for transmem- 
brane signaling with activation of phospholipases after ex- 
pressing  rogue  7-transmembrane  spanning  receptors  and 
addition of appropriate ligands (21, 26).  In the present ex- 
periments, CHO cells transfected with plNFll4 transduced 
signal in response to LXA4, by both activating GTPase (Fig. 
4) and releasing arachidonic acid (Fig. 5). Thus, the product 
encoded by plNFll4 specifically binds 3H-LXA4 and trans- 
duces signals with LXA4, indicating that plNFll4 is a can- 
didate for a functional LXA4 receptor.  This does not, how- 
ever, preclude the existence  of other LXA4 binding sites or 
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can transduce LXA4 signals. To date,  neither LTD4 receptors 
nor other receptors for LO-derived products have been cloned. 
LTD4  did displace  3H-LXA4  from  transfected  CHO  cells 
(Ki,  79.9 nM)  and gave '~65-70%  of the GTPase activity 
when  compared with  equimolar  amounts  of LXA4 (inset, 
Fig. 3). LTD4 competes for 3H-LXA4 binding  (5), and,  in 
certain  tissues,  LXA4  and  peptido-leukotrienes  appear  to 
share a common site of action (5, 10-12). Thus, the present 
findings suggest that certain types or subclasses  of peptido- 
leukotriene  receptors  may  be  structurally  related  to  the 
plNF114 encoded receptor. 
plNF114 and plNF154 were originally sequenced as FMLP- 
related receptors and coined "related formyl peptide receptors" 
(RFP) (16, 17). FPR transduces signal with FMLP (22), and 
FMLP clearly activates leukocytes; however, the endogenous 
ligands for these receptors have been questioned earlier (23). 
FMLP is a synthetic analogue and is thought  to be a sur- 
rogate of N-formylated, bacterial-derived proteins (23). An 
endogenous extraceUular  ligand for the FMLP receptor is not 
established.  Although  Carp  (27)  noted  that  N-formyl 
methionyl proteins from mitochondria of damaged cells are 
chemoattractant  for PMN and that this response is blocked 
with a FMLP receptor antagonist, it still remains unclear as 
to whether N-formylated proteins are unique ligands for the 
class of receptors (23).  The present results indicate that  at 
least one FPR receptor-related  sequence is a receptor for a 
lipid-derived ligand.  In this regard, it is of interest that the 
plNF114 gene has been mapped to chromosome 19, as have 
the genes for the complement component  5a receptor (16) 
and  the recently identified  thromboxane  A2 receptor gene 
(28).  The present results will now permit  further  analysis 
of LX site(s) of action, the mechanism underlying LXA4 re- 
sponses such as inhibition of neutrophil function (6-9), and 
elucidation of components involved in LX signal transduction. 
We thank  Mary Halm Small for skillful assistance in the preparation  of this manuscript. 
This work was supported in part by National Institutes of Health grant GM-38765 and the Pew Charitable 
Trusts (to C. N. Serhan). C. N. Serhan is a recipient of an Established Investigator Award from the Amer- 
ican Heart Association. S. Fiore is the recipient of the 1992 Frederic C. McDuffie Fellowship from the 
National  Arthritis  Foundation. 
Address correspondence to Dr. Charles N. Serhan, Brigham and Women's Hospital, Longwood Medical 
Research Center,  Ran. 611, 221 Longwood Avenue, Boston,  MA 02115. 
Received for publication  11 January  1994 and in  revised form  15 March  1994. 
References 
1.  Samuelsson, B., S.-E. Dahl~n, J.A. Lindgren,  C.A. Rouzer, 
and C.N. Serhan. 1987. Leukotrienes and lipoxins: structures, 
biosynthesis, and biological effects.  Science (Wash. DC). 237:1171. 
2.  Serhan, C.N.  1994. Lipoxin biosynthesis  and its impact  in 
inflammatory and vascular events. Biochim. Biopkys. Acta. 1212:1. 
3.  Nigam, S., S. Fiore, F.W. Luscinskas, and C.N. Serhan. 1990. 
Lipoxin A4 and lipoxin B4 stimulate the release but not the 
oxygenation of arachidonic acid in human neutrophils: dissoci- 
ation between lipid remodeling and adhesion. J. Cell. Physiol. 
143:512. 
4.  Fiore, S., S.W. Ryeom, P.F. WeUer, and C.N. Serhan. 1992. 
Lipoxin recognition  sites: spedfic binding of labeled lipoxin 
A4 with human  neutrophils. J. Biol. Chem.  267:16168. 
5.  Fiore, S., M. Romano, E.M. Reardon, and C.N. Serhan. 1993. 
Induction  of functional  lipoxin A4 receptors in HL-60 cells. 
Blood. 81:3395. 
6.  Lee, T.H., C.E. Horton, U. Kyan-Aung, D. Haskard, A.E.G. 
Crea, and B.W. Spur. 1989. Lipoxin A4 and lipoxin B4 inhibit 
chemotactic responses of human neutrophils stimulated by leu- 
kotriene  B4 and N-formyl-r-methionyl-r-leucyl-r-phenylala- 
nine. Clin. Sci. (Lond.). 77:195. 
7.  Lee, T.H., P. Lympany, A.E.G. Crea,  and B.W. Spur. 1991. 
Inhibition  of leukotriene B4-induced neutrophil  migration by 
lipoxin A4: structure-function  relationships. Biochem. Biophys. 
Res. Commun.  180:1416. 
8.  Colgan, S.P., C.N. Serhan, C.A. Parkos, C. Delp-Archer, and 
J.L. Madara. 1993. Lipoxin A4 modulates  transmigration  of 
human  neutrophils  across intestinal epithelial monolayers. J. 
Clin. Invest. 92:75. 
9.  Hedqvist, P., J.  Raud,  U.  Palmertz,  J.  Haeggstr6m,  K.C. 
Nicolaou, and S.-E. Dahl6n. 1989. Lipoxin A4 inhibits leuko- 
triene B4 induced inflammation in the hamster cheek pouch. 
Acta Physiol. Scand. 137:571. 
10.  Badr, K.F., D.K. DeBoer, M. Schwartzberg, and C.N. Serhan. 
1989. Lipoxin A4 antagonizes cellular and in vivo actions of 
leukotriene D4 in rat glomerular mesangial cells: evidence for 
competition at a common receptor. Proc. Natl. Acad. Sci. USA. 
86:3438. 
11.  Dah16n, S.-E., L. Franz6n, J. Raud, C.N. Serhan, P. West- 
lund, E. Wikstr6m, T. Bj6rck, H. Matsuda, S.E. Webber, C.A. 
Veale, et al.  1988. Actions  of lipoxin  A4 and related com- 
pounds in smooth muscle preparations and on the microcircu- 
lation  in vivo. Adv. Exp.  Med. Biol. 229:107. 
12.  Christie,  P.E., B.W. Spur, and T.H. Lee. 1992. The effects of 
lipoxin A4 on airway responses in asthmatic subjects. Am. Rev. 
Respir. Dis. 145:1281. 
259  Fiore et al. 13.  Perez, H.D., E. Kelly, and K. Holmes.  1992. Regulation  of 
formyl peptide receptor expression  and its mRNA levels  during 
differentiation of HL-60 cells. J. Biol. Chem.  267:358. 
14.  Naccache, P.H., T.F.P. Molski, B. SpineUi, P. Borgeat, and C.N. 
Abboud. 1984. Development of calcium and secretory  responses 
in the human promyelocytic leukemia cell line HL60. J. Cell. 
Physiol. 119:241. 
15.  Boulay, F., M. Tardif, L. Brouchon, and P. Vignais. 1990. Syn- 
thesis and use of a novel N-formyl peptide derivative to isolate 
a human N-formyl peptide receptor cDNA. Biochem. Biophys. 
Res. Commun.  168:1103. 
16.  Bao, L.,  N.P.  Gerard,  R.L. Eddy, Jr.,  T.B. Shows, and C. 
Gerard. 1992. Mapping of genes for the human C5a receptor 
(CSAR),  human  FMLP receptor  (FPR),  and  two  FMLP 
receptor homologue orphan receptors (FPRH1,  FPRH2) to 
chromosome 19. Genomics. 13:437. 
17.  Perez,  H.D., R. Holmes, E. Kelly,  J. McClary, and W,H. An- 
drews. 1992. Cloning of a cDNA encoding a receptor related 
to the formyl peptide receptor of human neutrophils.  Gene 
(Amst.).  118:303. 
18.  B6yum, A. 1968. Isolation of mononuclear cells and granulo- 
cytes from human blood. Scand.J. Clin. Lab. Invest. 21 (Suppl. 
97):77. 
19.  Lopata, M.A., D.W. Cleveland, and B. Sollner-Webb. 1984. 
High level transient  expression of a chloramphenicol acetyl 
transferase gene by DEAE-dextran  mediated DNA transfec- 
tion coupled with a dimethyl sulfoxide or glycerol shock treat- 
ment. Nucleic Acids Res.  12:5707. 
20.  Cassel, D., and Z. Selinger. 1976. Catecholamine-stimulated 
GTPase activity in turkey erythrocyte membranes. Biochim. Bio- 
phys. Acta.  452:538. 
21.  Piomelli, D., C. Pilon, B. Giros, P. Sokoloff, M.-P. Martres, 
and J.-C. Schwartz. 1991. Dopamine activation of the arachi- 
donic acid cascade as a basis for D1/D~ receptor synergism. 
Nature (Lond.). 353:164. 
22.  Perez,  H.D., R. Holmes, L.R. V'rlander,  R.K. Adams, W. Man- 
zana, D. Jolley, and W.H. Andrews. 1993. Formyl peptide 
receptor chimeras define domains involved in ligand binding. 
J. Biol. Chem.  268:2292. 
23.  Becket,  E.L. 1987. The formylpeptide receptor of the neutro- 
phil: a search and conserve operation. Am. J. Pathol. 129:16. 
24.  Perez,  H.D., R. Holmes, E. Kelly,  J. McClary, Q. Chou, and 
W.H. Andrews. 1992. Cloning of the gene coding for a human 
receptor for formyl peptides. Characterization of a promoter 
region and evidence for polymorphic expression. Biochemistry. 
31:11595. 
25.  Stoddard, B.L., H.-P. Biemann, and D.E. Koshland, Jr. 1992. 
Receptors and transmembrane signaling. Cold Spring Harbor 
Symp.  Quant. Biol. 57:1. 
26.  Aramori,  I.,  and S.  Nakanishi.  1992. Coupling  of two en- 
dothelin receptor subtypes to differing signal transduction in 
transfected Chinese hamster ovary cells. J. Biol. Chem.  267: 
12468. 
27.  Carp, H. 1982. Mitochondrial N-formylmethionyl proteins as 
chemoattractants  for neutrophils. J. Exp. Med. 155:264. 
28.  Niising, K.M., M. Hirata, A. Kakizuka, T. Eki, K. Ozawa, 
and S. Narumiya.  1993. Characterization  and chromosomal 
mapping of the human thromboxane As receptor gene.  J. Biol. 
Chem.  268:25253. 
260  Lipoxin  A4 Receptor Is a Serpentine Receptor 